P554: RESULTS OF A RANDOMIZED PLACEBO-CONTROLLED PHASE 2 STUDY OF HYPOMETHYLATING AGENTS WITH OR WITHOUT ELTROMBOPAG IN ELDERLY AML PATIENTS (DELTA)

• Katja Sockel,
• Anke Mütherig,
• Martina Crysandt,
• Mathias Hänel,
• Richard Noppeney,
• Kerstin Schaefer-Eckart,
• Martin Kaufmann,
• Christoph Röllig,
• Johannes Schetelig,
• Sven Zukunft,
• Frank Fiebig,
• Aristoteles Giagounidis,
• Sebastian Scholl,
• Andreas Lück,
• Kathrin Rieger,
• Katharina Götze,
• Thomas Geer,
• Philipp Kiewe,
• Carsten Müller-Tidow,
• Hubert Serve,
• Claudia Baldus,
• Ulrich Kaiser,
• Stefan Mahlmann,
• Burkhard Schmidt,
• Stefani Parmentier,
• Thomas Illmer,
• Ruth Seggewiß-Bernhardt,
• Alexander Kiani,
• Hartmut Linde,
• Heinz Dürk,
• Michael Kramer,
• Desiree Kunadt,
• Katharina Schmidt-Brücken,
• Jana Hase,
• Susann Helas,
• Jan Moritz Middeke,
• Malte von Bonin,
• Uta Oelschlaegel,
• Gerhard Ehninger,
• Christian Thiede,
• Martin Bornhauser,
• Uwe Platzbecker

Affiliations

Katja Sockel

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Anke Mütherig

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Martina Crysandt

2 RWTH Aachen University, Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Aachen, Germany

Mathias Hänel

3 Klinikum Chemnitz GmbH, Department of Internal Medicine 3, Chemnitz, Germany

Richard Noppeney

4 University Hospital Essen, Department of Hematology, Essen, Germany

Kerstin Schaefer-Eckart

5 Klinikum Nürnberg, Klinik für Innere Medizin 5, Nuernberg, Germany

Martin Kaufmann

6 Robert-Bosch-Krankenhaus, Abteilung für Hämatologie, Onkologie und Palliativmedizin, Stuttgart, Germany

Christoph Röllig

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Johannes Schetelig

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Sven Zukunft

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Frank Fiebig

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Aristoteles Giagounidis

7 Marien Hospital Düsseldorf, Department of Oncology, Hematology and Palliative Care, Düsseldorf, Germany

Sebastian Scholl

8 Jena University Hospital, Department of Internal Medicine II, Jena, Germany

Andreas Lück

9 Wissenschaftskontor Nord GmbH & Co KG, Outpatient Center for Urology and Oncology, Rostock, Germany

Kathrin Rieger

10 Charité Berlin, Department of Hematology, Oncology and Cancer Immunology, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Katharina Götze

11 Klinikum rechts der Isar, Technische Universität München, Medical Department III for Hematology and Oncology, Munich, Germany

Thomas Geer

12 Diakonie Klinikum Schwäbisch-Hall, Innere Medizin III, Schwäbisch Hall, Germany

Philipp Kiewe

13 Onkologischer Schwerpunkt am Oskar-Helene-Heim, Berlin, Germany

Carsten Müller-Tidow

14 University Hospital Heidelberg, Department of Medicine V, Heidelberg, Germany

Hubert Serve

15 University Hospital Frankfurt, Goethe University, Frankfurt Cancer Institute, Goethe University Frankfurt; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Frankfurt, Germany

Claudia Baldus

16 Universitätsklinikum Schleswig-Holstein, Klinik für Innere Medizin II, Kiel, Germany

Ulrich Kaiser

17 St Bernward Krankenhaus, Medizinische Klinik II, Hildesheim, Germany

Stefan Mahlmann

18 Westpfalz-Klinikum GmbH, Klinik für Innere Medizin 1, Kaiserslautern, Germany

Burkhard Schmidt

19 Gemeinschaftspraxis Hämato-Onkologie Pasing, Munich, Germany

Stefani Parmentier

20 Claraspital Basel, Department of Hematology, Basel, Switzerland

Thomas Illmer

21 GOKOS GmbH, Dresden, Germany

Ruth Seggewiß-Bernhardt

22 Sozialstiftung Bamberg, Department of Internal Medicine V, Bamberg, Germany

Alexander Kiani

23 Klinikum Bayreuth GmbH, Department of Medicine IV, Bayreuth, Germany

Hartmut Linde

24 MVZ für Blut- und Krebserkrankungen Potsdam, Potsdam, Germany

Heinz Dürk

25 St. Marien-Hospital Hamm, Klinik Hämatologie und Onkologie, Hamm, Germany

Michael Kramer

26 AvenCell Europe GmbH Dresden, Dresden, Germany

Desiree Kunadt

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Katharina Schmidt-Brücken

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Jana Hase

26 AvenCell Europe GmbH Dresden, Dresden, Germany

Susann Helas

26 AvenCell Europe GmbH Dresden, Dresden, Germany

Jan Moritz Middeke

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Malte von Bonin

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Uta Oelschlaegel

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Gerhard Ehninger

26 AvenCell Europe GmbH Dresden, Dresden, Germany

Christian Thiede

27 AgenDix GmbH, Dresden, Germany

Martin Bornhauser

1 University Hospital Dresden, TU Dresden, Medical Department 1, Dresden, Germany

Uwe Platzbecker

28 University Hospital Leipzig, Clinic and Polyclinic for Haematology, Cell Therapy and Hemostaseology, Leipzig, Germany